SMTL ID : 3igv.1 (1 other biounit)

Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydro-pyridinone inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x B80: N-{3-[(6S)-6-ethyl-1-(4-fluorobenzyl)-4-hydroxy-2-oxo-1,2,5,6-tetrahydropyridin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide(Non-covalent)

B80.1: 18 residues within 4Å: Chain A: F.193, P.197, R.200, S.288, N.291, N.316, G.317, D.318, C.366, S.368, L.384, N.411, M.414, Y.415, I.447, Y.448, G.449, S.556 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.384, A:Y.448 Hydrogen bonds: A:N.291, A:D.318, A:D.318, A:Y.448, A:G.449 Water bridges: A:S.556, A:S.556 pi-Stacking: A:F.193

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ellis, D.A. et al., 5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-12-08

Peptides

RNA-DIRECTED RNA POLYMERASE: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RNA-DIRECTED RNA POLYMERASE

Related Entries With Identical Sequence